Organizations sign Memorandum of Understanding to increase opportunities for medical technology companies and foster the growth of the industry
Toronto and Halifax (June 25, 2015) – MEDEC, the national association representing Canada’s Medical Technology companies and BioNova, the Nova Scotia Biotechnology and Life Sciences Industry Association, are pleased to announce the signing of a Memorandum of Understanding that will leverage the regional strengths of each association for the benefit of patients, and the medical technology industry.
This agreement will enable member companies of each organization to have access to programs, advocacy efforts and industry knowledge offered by each association. Members of each organization will benefit from:
- Greater opportunities to participate in advocacy initiatives at the national and provincial level
- Access to respective member training and educational programs
- Reciprocal distribution of each association’s relevant member communications
This collaboration will advance health outcomes for patients and grow the medical technology industry by enhancing each association’s work with governments and health system partners to increase patient access to innovative medical technologies and improve commercialization opportunities.
“This agreement will accelerate the development of medical technology companies in Nova Scotia – supporting the local economy and giving Nova Scotians a voice for issues on a federal level,” said Scott Moffitt, Managing Director of BioNova. “We’re very pleased about this partnership and look forward to working closely with MEDEC.”
“MEDEC supports Canadian innovation by working with our partners in government and healthcare organizations in order to ensure that patients have access to innovative medical technologies that enhance patient care and increase the sustainability of our healthcare system,” said Brian Lewis, President and CEO of MEDEC. “This agreement with BioNova allows us to have greater engagement in Nova Scotia and to harness a greater understanding of the needs of the many cutting-edge companies that are located there.”
BioNova leads and supports its members as they build a successful, self-sustaining life sciences industry in Nova Scotia, one that is based on a foundation of competitive advantage and is creating wealth for Nova Scotians.
BioNova is Nova Scotia’s life sciences organization, representing companies working in drug & vaccine development, medical technologies, natural health products & nutraceuticals, digital
health and bioproducts, as well as research organizations, service providers and other supporters.
MEDEC is the national association representing the medical technology industry in Canada. Our members are committed to providing safe and innovative medical technologies that enhance the quality of patient care, improve patient access to health care, and help enable the sustainabilityof ourpublicly-fundedhealthcaresystem.Themedicaltechnologyindustryin Canada employs over 35,000 Canadians in approximately 1,500 facilities, and has sales of over $7 billion per annum. We are committed to supporting the growth of a strong and vibrant medical technology industry that contributes to Canada’s innovation economy.
Shana McRae, Marketing and Communications Officer, BioNova (902) 421-5705 Ext. 2
Gerry Frenette, Executive Director, Public and Member Relations, MEDEC (416) 620-1915 ext. 227